NCT01589757 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Ceriello A
Acute hyperglycaemia and oxidative stress generation. Diabet Med. 1997 Aug;14 Suppl 3:S45-9. Review.
Ceriello A
The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med. 1998 Mar;15(3):188-93. Review.
Elisia I, Kitts DD
Quantification of hexanal as an index of lipid oxidation in human milk and association with antioxidant components. J Clin Biochem Nutr. 2011 Nov;49(3):147-52. doi: 10.3164/jcbn.10-142. Epub 2011 Sep 3.
Grant SM, Wolever TM
Perceived barriers to application of glycaemic index: valid concerns or lost in translation? Nutrients. 2011 Mar;3(3):330-40. doi: 10.3390/nu3030330. Epub 2011 Feb 28. Review.
Huang D, Ou B, Prior RL
The chemistry behind antioxidant capacity assays. J Agric Food Chem. 2005 Mar 23;53(6):1841-56. Review.
Saenz AT, Elisia I, Innis SM, Friel JK, and Kitts DD
Use of ORAC to assess antioxidant capacity of human milk. Journal of Food Composition and Analysis 22:694-698, 2009
Wolever, TMS
The Glycaemic Index: A Physiological Classification of Dietary Carbohydrate. Ontario, Canada: CABI, 2006.

The Effect of a Low GI Diet on Maternal and Neonatal Markers of Glycaemic Control and Postpartum Diabetes Risk SUBSTUDY The Effect of a Low GI Diet on Postpartum Markers of Oxidation in Breast Milk of Women With Gestational Hyperglycaemia

Details for clinical trial NCT01589757

Clinical trial NCT01589757 - References